http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104311445-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
filingDate 2014-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104311445-B
titleOfInvention Naphthalene-ring containing succinamide derivative, Preparation Method And The Use
abstract The present invention relates to the pharmaceutical field relevant to hyperuricemia and gout.Specifically, the present invention relates to uric acid transporter body 1 inhibitor of the naphthalene-ring containing succinamide structure of a class, its preparation method and preparing the application in diabetes medicament containing their pharmaceutical composition and they.n wherein, Rn 1 be selected from H, Cn 1 -Cn 5 alkyl, Cn 3 -Cn 6 cycloalkyl; Rn 2 be selected from H, Cn 1 -Cn 5 alkyl, Cn 3 -Cn 6 cycloalkyl.
priorityDate 2014-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014131374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014065413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5572145-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3632646-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6930703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421969869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411538925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135401907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449982031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9886157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53465279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451114410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450024817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135847945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420859410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411875152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426123352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425786122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392965
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID365398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718

Total number of triples: 59.